A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation

Journal of Cell Biology

Volumn 155, Issue 7, 2001, Pages 1333-1344

  Jiménez, Maria J G ^a   Balbín, Milagros ^a   Alvarez, Jesús ^b   Komori, Toshihisa ^c   Bianco, Paolo ^d   Holmbeck, Kenn ^e   Birkedal Hansen, Henning ^e   López, José M ^b   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Arthritis; Bone formation; Cancer; Metastasis; Proteases

Indexed keywords

CELL MARKER; COLLAGEN TYPE 2; COLLAGENASE 3; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; METATARSAL BONE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERICHONDRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0035945361     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200106147     Document Type: Article

References (57)

1. Different bone growth rates are associated with changes in the expression pattern of types II and X collagens and collagenase 3 in proximal growth plates of the rat tibia
2. Cloning of the human and mouse type X collagen genes and mapping of the mouse type X collagen gene to chromosome 10
3. Expression of collagenase-3 in the rat ovary during the ovulatory process
4. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors
5. Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprorease genes independent of TGF-β
6. Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter
7. Chondrocyte differentiation
8. Individual osteoblasts in the developing calvaria express different gene repertoires
9. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation
10. Retinoic acid stimulates interstitial collagenase messenger ribonucleic acid in osteosarcoma cells
11. Retinoic acid is a potent regulator of growth plate chondrogenesis
12. Characterization of retinoic acid-induced AP-1 activity in B16 mouse melanoma cells
13. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
14. Serotonin-mediated production of interstitial collagenase by uterine smooth muscle cells requires interleukin-lα, but not interleukin-1β
15. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
16. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
17. Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells
18. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression
19. Retinoids in development
20. MT1-MMP-defficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
21. Retinoic acid is a major regulator of chondrocyte maturation and matrix mineralization
22. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
23. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase
24. The genetic transformation of bone biology
25. Cellular mechanisms for human procollagenase-3 (MMP-13) activation
26. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
27. Retinoid signaling is required for chondrocyte maturation and endochondral bone formation during limb skeletogenesis
28. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption
29. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site
30. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium
31. Retinoids and chemoprevention: Clinical and basic studies
32. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
33. Expression of collagenase-3 (MMP-13) in human abdominal aorric aneurysms and vascular smooth muscle cells in culture
34. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-α1(II) collagen gene
35. Matrix metalloproteinases
36. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site
37. Retinoic acid treatment elevates matrix metalloproteinase-2 protein and mRNA levels in avian growth plate chondrocyte cultures
38. The regulation and regulatory role of collagenase in bone
39. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13)
40. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone
41. Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase
42. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase
43. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: Evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun
44. Retinoic acid is a negative regulator of AP-1-responsive genes
45. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor α1
46. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis
47. Induction of the collagenase phorbol ester response element by staurosporine
48. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis
49. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
50. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation
51. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
52. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions
53. Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts
54. Regulation of interstitial collagenase expression and collagen degradation by retinoic acid in bone cells
55. ECM and cell surface proteolysis: Regulating cellular ecology
56. Regulation of matrix metalloproceinase expression in tumor invasion
57. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1